REGENXBIO Inc. (RGNX): Price and Financial Metrics
RGNX Price/Volume Stats
| Current price | $8.66 | 52-week high | $15.36 |
| Prev. close | $9.16 | 52-week low | $5.03 |
| Day low | $8.62 | Volume | 671,600 |
| Day high | $9.32 | Avg. volume | 1,068,291 |
| 50-day MA | $8.50 | Dividend yield | N/A |
| 200-day MA | $8.79 | Market Cap | 434.39M |
RGNX Stock Price Chart Interactive Chart >
REGENXBIO Inc. (RGNX) Company Bio
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.
RGNX Price Returns
| 1-mo | -2.59% |
| 3-mo | 1.88% |
| 6-mo | 16.87% |
| 1-year | -25.60% |
| 3-year | -58.94% |
| 5-year | -76.63% |
| YTD | 12.03% |
| 2024 | -56.94% |
| 2023 | -20.86% |
| 2022 | -30.64% |
| 2021 | -27.91% |
| 2020 | 10.72% |
Continue Researching RGNX
Want to do more research on REGENXBIO Inc's stock and its price? Try the links below:REGENXBIO Inc (RGNX) Stock Price | Nasdaq
REGENXBIO Inc (RGNX) Stock Quote, History and News - Yahoo Finance
REGENXBIO Inc (RGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...